reperfusion injury, myocardial
Showing 1 - 7 of 7
Myocardial Infarction, Reperfusion Injury, Myocardial Trial in Uxbridge (Transcoronary cooling and dilution, Standard of care)
Recruiting
- Myocardial Infarction
- Reperfusion Injury, Myocardial
- Transcoronary cooling and dilution
- Standard of care
-
Uxbridge, United KingdomHarefield Hospital
Nov 7, 2023
Reperfusion Injury, Myocardial Trial in Jakarta Pusat (Colchicine, Placebo (lactose))
Enrolling by invitation
- Reperfusion Injury, Myocardial
- Colchicine
- Placebo (lactose)
-
Jakarta Pusat, Jakarta, IndonesiaFakultas Kedokteran Universitas Indonesia
Feb 8, 2023
Acute Myocardial Infarction, Ischemia-reperfusion Injury, Reperfusion Injury, Myocardial Trial in Santiago de Chile (Antioxidant
Recruiting
- Acute Myocardial Infarction
- +4 more
- Antioxidant formula
- Dextrose 5% in water
-
Santiago de Chile, ChileUniversity of Chile
Jan 17, 2022
Coronary Artery Disease, Coronary Artery Bypass, Cardiopulmonary Bypass Trial (Nitric Oxide, Standard CPB)
Completed
- Coronary Artery Disease
- +4 more
- Nitric Oxide
- Standard CPB
- (no location specified)
Jul 1, 2019
CMR to Assess Severity and Prognosis of Reperfusion Injury After
Unknown status
- STEMI - ST Elevation Myocardial Infarction
- Reperfusion Injury, Myocardial
- Treg levels and CMR results
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Jun 25, 2019
Reperfusion Injury, Myocardial Trial (Empagliflozin, )
Unknown status
- Reperfusion Injury, Myocardial
- Empagliflozin
- placebo
- (no location specified)
Jul 17, 2018
Reperfusion Injury, Myocardial Trial in Beijing (melatonin (Helsinn Chemical Co, Biasca, Switzerland), Placebos)
Unknown status
- Reperfusion Injury, Myocardial
- melatonin (Helsinn Chemical Co, Biasca, Switzerland)
- Placebos
-
Beijing, Beijing, ChinaPLA General Hospital
Oct 4, 2017